Amplitude Vascular Systems
PrivateLast Round
Series B
Jan 28, 2025
Total Funding Raised
$56M
Momentum Score
25 /100
Company Overview
Amplitude Vascular Systems is a medical device company that develops and commercializes the Pulse IVL™ System, a pulsatile intravascular lithotripsy (PIVL) therapy to treat severely calcified arterial disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amplitude Vascular Systems Comps
Public and private peers based on sector, stage, and business model.
Amplitude Vascular Systems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 28, 2025 | ||||
| Series B | Jan 5, 2023 |
Key People
Founding team and executive leadership
Amplitude Vascular Systems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioStar Capital | Series B |
| CUE Growth Partners | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 28, 2025
$36M round completed.
Amplitude Vascular Systems Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Amplitude Vascular Systems's valuation, stock price, and market status.
